Literature DB >> 18004559

X-ray absorption and diffraction studies of the metal binding sites in amyloid beta-peptide.

Victor Streltsov1.   

Abstract

A major source of neurodegeneration observed in Alzheimer's disease is believed to be caused by the toxicity from reactive oxygen species produced in the brain mediated by the A beta protein and mainly copper species. An atomic model of an amyloid beta-peptide (A beta) Cu2+ complex or at least the structure of the metal binding site is of great interest. Accurate information about the Cu-binding site of A beta protein can facilitate simulation of redox chemistry using high level quantum mechanics. Complementary X-ray diffraction and X-ray absorption techniques can be employed to obtain such accurate information. This review provides a blend of X-ray diffraction results on amyloid structures and selected works on A beta Cu2+ binding based on spectroscopic measurements with emphasis on the X-ray absorption technique.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18004559     DOI: 10.1007/s00249-007-0232-5

Source DB:  PubMed          Journal:  Eur Biophys J        ISSN: 0175-7571            Impact factor:   1.733


  46 in total

1.  Metal ions, pH, and cholesterol regulate the interactions of Alzheimer's disease amyloid-beta peptide with membrane lipid.

Authors:  Cyril C Curtain; Fedá E Ali; Danielle G Smith; Ashley I Bush; Colin L Masters; Kevin J Barnham
Journal:  J Biol Chem       Date:  2002-11-14       Impact factor: 5.157

2.  Beta-structures in fibrous proteins.

Authors:  Andrey V Kajava; John M Squire; David A D Parry
Journal:  Adv Protein Chem       Date:  2006

Review 3.  Structural models of amyloid-like fibrils.

Authors:  Rebecca Nelson; David Eisenberg
Journal:  Adv Protein Chem       Date:  2006

4.  Structural and thermodynamical properties of CuII amyloid-beta16/28 complexes associated with Alzheimer's disease.

Authors:  Luc Guilloreau; Luminita Damian; Yannick Coppel; Honoré Mazarguil; Mathias Winterhalter; Peter Faller
Journal:  J Biol Inorg Chem       Date:  2006-08-22       Impact factor: 3.358

5.  Engineering metal ion coordination to regulate amyloid fibril assembly and toxicity.

Authors:  Jijun Dong; Jeffrey M Canfield; Anil K Mehta; Jacob E Shokes; Bo Tian; W Seth Childers; James A Simmons; Zixu Mao; Robert A Scott; Kurt Warncke; David G Lynn
Journal:  Proc Natl Acad Sci U S A       Date:  2007-08-08       Impact factor: 11.205

6.  Methylation of the imidazole side chains of the Alzheimer disease amyloid-beta peptide results in abolition of superoxide dismutase-like structures and inhibition of neurotoxicity.

Authors:  Anna K Tickler; Danielle G Smith; Giuseppe D Ciccotosto; Deborah J Tew; Cyril C Curtain; Darryl Carrington; Colin L Masters; Ashley I Bush; Robert A Cherny; Roberto Cappai; John D Wade; Kevin J Barnham
Journal:  J Biol Chem       Date:  2005-01-24       Impact factor: 5.157

7.  Metal binding modes of Alzheimer's amyloid beta-peptide in insoluble aggregates and soluble complexes.

Authors:  T Miura; K Suzuki; N Kohata; H Takeuchi
Journal:  Biochemistry       Date:  2000-06-13       Impact factor: 3.162

8.  NMR reveals anomalous copper(II) binding to the amyloid Abeta peptide of Alzheimer's disease.

Authors:  Liming Hou; Michael G Zagorski
Journal:  J Am Chem Soc       Date:  2006-07-26       Impact factor: 15.419

9.  Metal switch for amyloid formation: insight into the structure of the nucleus.

Authors:  David M Morgan; Jijun Dong; Jaby Jacob; Kun Lu; Robert P Apkarian; Pappannan Thiyagarajan; David G Lynn
Journal:  J Am Chem Soc       Date:  2002-10-30       Impact factor: 15.419

10.  Metalloenzyme-like activity of Alzheimer's disease beta-amyloid. Cu-dependent catalytic conversion of dopamine, cholesterol, and biological reducing agents to neurotoxic H(2)O(2).

Authors:  Carlos Opazo; Xudong Huang; Robert A Cherny; Robert D Moir; Alex E Roher; Anthony R White; Roberto Cappai; Colin L Masters; Rudolph E Tanzi; Nibaldo C Inestrosa; Ashley I Bush
Journal:  J Biol Chem       Date:  2002-08-20       Impact factor: 5.157

View more
  5 in total

Review 1.  Nanomechanics of functional and pathological amyloid materials.

Authors:  Tuomas P J Knowles; Markus J Buehler
Journal:  Nat Nanotechnol       Date:  2011-07-31       Impact factor: 39.213

2.  The structure of the amyloid-beta peptide high-affinity copper II binding site in Alzheimer disease.

Authors:  Victor A Streltsov; Stephen J Titmuss; V Chandana Epa; Kevin J Barnham; Colin L Masters; Joseph N Varghese
Journal:  Biophys J       Date:  2008-07-03       Impact factor: 4.033

3.  Amyloid plaques in PSAPP mice bind less metal than plaques in human Alzheimer's disease.

Authors:  Andreana C Leskovjan; Antonio Lanzirotti; Lisa M Miller
Journal:  Neuroimage       Date:  2009-05-28       Impact factor: 6.556

Review 4.  Pharmacotherapeutic targets in Alzheimer's disease.

Authors:  Yif'at Biran; Colin L Masters; Kevin J Barnham; Ashley I Bush; Paul A Adlard
Journal:  J Cell Mol Med       Date:  2008-11-18       Impact factor: 5.310

5.  His6, His13, and His14 residues in Aβ 1-40 peptide significantly and specifically affect oligomeric equilibria.

Authors:  Kaja Przygońska; Magdalena Pacewicz; Wiktoria Sadowska; Jarosław Poznański; Wojciech Bal; Michał Dadlez
Journal:  Sci Rep       Date:  2019-07-01       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.